Moderna is suing Pfizer over its coronavirus vaccine
Moderna is suing Pfizer and BioNTech over alleged infringement of its mRNA vaccine know-how patents, the corporate introduced as we speak.
“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic,” mentioned Moderna chief government officer Stéphane Bancel in a statement.
Moderna mentioned in 2020 that it could not implement its patents throughout the pandemic to permit for an unhindered public well being response. It’s nonetheless not planning to implement patents in low- and middle-income international locations, the corporate mentioned in a press release. But it’s coming after Pfizer and BioNTech, which it mentioned it anticipated to “respect its intellectual property rights.” In the filing, the corporate mentioned, “Moderna refrained from asserting its patents earlier so as not to distract from efforts to bring the pandemic to an end as quickly as possible.”
The lawsuit shouldn’t have a significant impact on vaccine availability — Moderna mentioned in its assertion that it’s not trying to take away the Pfizer / BioNTech vaccine, recognized commercially as Comirnaty, from the market. It’s on the lookout for cost, mentioned Shannon Thyme Klinger, Moderna’s chief authorized officer, within the assertion: “Moderna expects Pfizer and BioNTech to compensate Moderna for Comirnaty’s ongoing use of Moderna’s patented technologies.”
Moderna and Pfizer / BioNTech each developed COVID-19 vaccines utilizing mRNA. The photographs introduce tiny snippets of the coronavirus’ genetic materials to the physique for it to create antibodies towards.